Literature DB >> 21976041

[Diagnose importance of multiparametric magnetic resonance tomography for prostate cancer].

B J Fueger1, T H Helbich, M Schernthaner, S Zbýn, H G Linhart, A Stiglbauer, A Doan, K Pinker, G Heinz, A R Padhani, P Brader.   

Abstract

Prostate cancer is biologically and clinically a heterogeneous disease which makes imaging evaluation challenging. Magnetic resonance imaging (MRI) has considerable potential to improve prostate cancer detection and characterization. Until recently morphologic MRI has not been routinely incorporated into clinical care because of its limitation to detect, localize and characterize prostate cancer. Performing prostate gland MRI using functional techniques has the potential to provide unique information regarding tumor behavior, including treatment response. In order for multiparametric MRI data to have an impact on patient management, the collected data need to be relayed to clinicians in a standardized way for image construction, analysis and interpretation. This will ensure that patients are treated effectively and in the most appropriate way. Scoring systems similar to those employed successfully for breast imaging need to be developed.

Entities:  

Mesh:

Year:  2011        PMID: 21976041     DOI: 10.1007/s00117-011-2179-x

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  35 in total

Review 1.  Combined PET/MRI: a new dimension in whole-body oncology imaging?

Authors:  Gerald Antoch; Andreas Bockisch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

2.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

3.  Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system.

Authors:  Juyoung A Jung; Fergus V Coakley; Daniel B Vigneron; Mark G Swanson; Aliya Qayyum; Vivian Weinberg; Kirk D Jones; Peter R Carroll; John Kurhanewicz
Journal:  Radiology       Date:  2004-12       Impact factor: 11.105

Review 4.  How good is MRI at detecting and characterising cancer within the prostate?

Authors:  Alexander P S Kirkham; Mark Emberton; Clare Allen
Journal:  Eur Urol       Date:  2006-06-30       Impact factor: 20.096

5.  Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.

Authors:  Thomas Hambrock; Diederik M Somford; Caroline Hoeks; Stefan A W Bouwense; Henkjan Huisman; Derya Yakar; Inge M van Oort; J Alfred Witjes; Jurgen J Fütterer; Jelle O Barentsz
Journal:  J Urol       Date:  2009-12-14       Impact factor: 7.450

6.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.

Authors:  J Kurhanewicz; D B Vigneron; H Hricak; P Narayan; P Carroll; S J Nelson
Journal:  Radiology       Date:  1996-03       Impact factor: 11.105

7.  Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.

Authors:  Masoom A Haider; Peter Chung; Joan Sweet; Ants Toi; Kartik Jhaveri; Cynthia Ménard; Padraig Warde; John Trachtenberg; Gina Lockwood; Michael Milosevic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-19       Impact factor: 7.038

Review 8.  Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance.

Authors:  Arnauld Villers; Laurent Lemaitre; Jérémie Haffner; Philippe Puech
Journal:  Curr Opin Urol       Date:  2009-05       Impact factor: 2.309

9.  Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.

Authors:  Hyun Kyung Lim; Jeong Kon Kim; Kyung Ah Kim; Kyoung-Sik Cho
Journal:  Radiology       Date:  2008-11-18       Impact factor: 11.105

Review 10.  [Diagnostic radiology of the pelvis. Prostate cancer, bladder cancer, and incontinence].

Authors:  U G Mueller-Lisse M B A
Journal:  Radiologe       Date:  2008-04       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.